Bergapten (5-methoxypsoralen) is a naturally-occurring organic chemical compound produced by numerous plant species, especially from the carrot family Apiaceae and the citrus family Rutaceae. For example, bergapten has been extracted from 24 species of the genus Heracleum in the family Apiaceae.[1][2] In the family Rutaceae, various Citrus species contain significant amounts of bergapten,[3] especially the bergamot orange, the micrantha, and certain varieties of lime and bitter orange.
Bergapten belongs to a class of chemical compounds known as the furanocoumarins. In 1834, Kalbrunner isolated 5-methoxypsoralen from bergamot essential oil,[4] hence the common name "bergapten". It was the first furanocoumarin to be isolated and identified.
Toxicity
Bergapten is a derivative of psoralen, the parent compound of a family of naturally-occurring organic compounds known as the linear furanocoumarins (so called since they exhibit a linear chemical structure). Some of the linear furanocoumarins, including bergapten, act as strong photosensitizers when applied topically to the skin.
Bergapten is often found in plants associated with phytophotodermatitis,[5] a potentially serious skin inflammation. Contact with plant parts containing bergapten (and other linear furanocoumarins) followed by exposure to ultraviolet light may lead to phytophotodermatitis. In particular, bergapten appears to be the primary phototoxic compound responsible for Citrus-induced phytophotodermatitis.[3]
Bergapten and other linear furanocoumarins induce a loss of template activity for RNA synthesis. 5-methoxypsoralen has also been noted for its mutagenic effects as well as its capacity for being a very potent agent for inducing chromosome aberrations. With a high enough concentration, complete mitotic inhibition was observed.[4]
There is sufficient evidence that bergapten promotes cancer in animals but such evidence of carcinogenicity in humans is lacking. According to the International Agency for Research on Cancer, bergapten is probably carcinogenic to humans.[6]
Medical usages
Bergapten serves to have the skin absorb more light, and pigmentary diseases like vitiligo (leukodermia) and psoriasis have treatments involving furanocoumarins often in conjunction with sun exposure or solar radiation. In people who easily sunburn, furanocoumarins can also increase the tolerance of skin to solar radiation.[4] Bergapten was shown to elicit certain skin reactions in order to even out pigmentation lightening for vitiligo patients depending on various factors like the susceptibility of the subject, the dosage, and the humidity, but the effects may be inconsistent.[7]
With psoriasis, bergapten has been valued as an oral photochemotherapy treatment for its efficacy and lack of phototoxic and drug-insensitive reactions. It operates as a photosensitizing drug that is as effective or, with high enough dosage, more effective than 8-methoxypsoralen in the clearance of psoriasis lesions.[8] It has been shown to be a valuable alternative to 8-methoxypsoralen due to the relative lack of side effects during treatment like erythma, pruritus, and nausea.[9]
Bergapten has also been implicated as a potential prevention method for sunlight-related skin cancer. One study found that a tan gained with bergapten had less DNA damage in human subjects.[10] Bergapten has been shown to have anti-tumoral effects, like its ability to induce the autophagic process in breast cancer cells. One study suggested that this was possible through the up-regulation of PTEN gene expression in those breast cancer cells.[11]
Bergapten, alongside other furanocoumarins, has also been implicated in Cytochrome P450 inhibition.[12]
Synthesis
Condensed version of efficient synthesis of Bergapten
Bergapten is a natural compound coming from plants like the common fig, but it can also be synthesized. Most syntheses of linear furanocoumarins involve starting with a central aromatic unit and adding two heterocyclic rings. Alternate routes of synthesis are desirable to avoid regiochemical problems and moderate yields. The synthesis described here involves Iodine as a removable group to insure regiochemical integrity and convergence.[13] As shown in the diagram, phloroglucinol (compound 1) was the starting material. Mono-methylation was conducted followed by a reaction with ethyl propiolate in the presence of ZnCl2 to yield 7-hydroxy-5-methoxycoumarin (product 3, not shown) with 68% yield. The 8-position of 7-hydroxy-5-methoxycoumarin was then protected by iodine to avoid the formation of an angular furanocoumarin. Product 4 in the diagram is the result of that iodine protection. Product 5 was the result of the allylation of product 4. Osmium tetraoxide and sodium metaperiodate were used to oxidatively cleave the O-allyl derivative onto the aldehyde product 7 via a diol intermediate (product 6, not shown). Cyclization of the aldehyde product 7 using BF3-Et2O in tetra-n-butylammonium bromide was then conducted to construct the furan ring. The final step was to remove the iodine protective group via Pd(OAc)2 to ultimately produce bergapten (product 9) with 90% yield. Synthetic bergapten was isolated as a colorless compound with properties spectroscopically identical to the natural product.
A known use of bergapten is in the synthesis of Fraxinol.[14] The key reaction in this synthesis is the oxidation of the furan ring of visnagin and bergapten with chromic acid.[14]
References
^Nielsen, B. E. (1970). Coumarins of Umbelliferous plants. Copenhagen: Royal Danish School of Pharmacy. Cited by Mitchell and Rook (1979).
^Mitchell, John; Rook, Arthur (1979). Botanical Dermatology: Plants and Plant Products Injurious to the Skin. Vancouver: Greengrass. pp. 692–699.
^McGovern, Thomas W.; Barkley, Theodore M. (2000). "Botanical Dermatology". The Electronic Textbook of Dermatology. Internet Dermatology Society. Section Phytophotodermatitis. Retrieved November 29, 2018.
^Tanew, Adrian (February 1988). "5-Methoxypsoralen (Bergapten) for photochemotherapy: Bioavailability, phototoxicity, and clinical efficacy in psoriasis of a new drug preparation". Journal of the American Academy of Dermatology. 18 (2 Pt 1): 333–338. doi:10.1016/S0190-9622(88)70048-1. PMID3279089.
^Tisserand, Robert (2014). Essential Oil Safety. Churchill Livingstone.
^Aldred, Elaine (2009). Haschek and Rousseaux's Handbook of Toxicologic Pathology (Third ed.). Churchill livingstone.
^Oda, Kazuaki (June 2005). "An Efficient Synthesis of Bergapten". Heterocycles. 65 (8): 1985–1988. doi:10.3987/com-05-10451 (inactive 2024-02-17) – via ResearchGate.((cite journal)): CS1 maint: DOI inactive as of February 2024 (link)
^ abSchönberg, Alexander; Badran, Nasry; Starkowsky, Nicolas A. (1955). "Furo-chromones and -Coumarins. XII. Synthesis of Fraxinol from Bergapten and of Baicalein from Visnagin". Journal of the American Chemical Society. 77 (20): 5390–5392. doi:10.1021/ja01625a055. ISSN0002-7863.
